Neuren Pharmaceuticals (ASX:NEU) Accounts Payable : A$0.7 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Neuren Pharmaceuticals Accounts Payable?

Neuren Pharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2023 was A$0.7 Mil.

Neuren Pharmaceuticals's quarterly Accounts Payable increased from Dec. 2022 (A$0.3 Mil) to Jun. 2023 (A$3.1 Mil) but then declined from Jun. 2023 (A$3.1 Mil) to Dec. 2023 (A$0.7 Mil).

Neuren Pharmaceuticals's annual Accounts Payable increased from Dec. 2021 (A$0.2 Mil) to Dec. 2022 (A$0.3 Mil) and increased from Dec. 2022 (A$0.3 Mil) to Dec. 2023 (A$0.7 Mil).

Neuren Pharmaceuticals Accounts Payable Historical Data

The historical data trend for Neuren Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuren Pharmaceuticals Accounts Payable Chart

Neuren Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.34

0.17

0.25

0.26

0.68

Neuren Pharmaceuticals Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial															0.25	1.10	0.26	3.10	0.68

Neuren Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Neuren Pharmaceuticals Accounts Payable Related Terms

Thank you for viewing the detailed overview of Neuren Pharmaceuticals's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuren Pharmaceuticals (ASX:NEU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neuren Pharmaceuticals Ltd (ASX:NEU) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

NURPF:USA

Address

697 Burke Road, Suite 201, Camberwell, Melbourne, VIC, AUS, 3124

Website

https://www.neurenpharma.com

Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment, and neurodegenerative disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome.